Heparin but not citrate anticoagulation of blood preserves platelet function for prolonged periods

作者: N. J. TRUSS , P. C. J. ARMSTRONG , E. LIVERANI , I. VOJNOVIC , T. D. WARNER

DOI: 10.1111/J.1538-7836.2009.03589.X

关键词:

摘要: Summary. Background: Current guidelines state that platelet aggregation studies should be conducted within 4 h of venepuncture because the decline in sensitivity to agonists. This constrains activity clinical situations where samples need transported or there are unavoidable delays prior assessment. Objectives: The aim present study was compare systematically responses platelets stored presence either citrate heparin, two most widely used anti-coagulants, using a range standard techniques. Methods: Blood taken from healthy volunteers and assessed immediately at ambient temperature (18–25 °C) for 24 h. Platelet reactivity agonists determined by combination 96-well plate techniques; light transmission aggregometry, thrombi adhesion, ATP ADP release, TxA2 release; whole blood aggregometry; PFA-100. Results conclusions: Testing techniques allowed simultaneous measurement multiple concentrations The anti-coagulated with heparin were predominantly preserved all assays after 24 h storage, whereas, greatly diminished. Consequently, anti-coagulation but not citrate, preserves up 24 h as

参考文章(30)
J B Smith, S F Mohammad, H Y Chuang, R G Mason, W H Anderson, Effects of heparin on platelet aggregation and release and thromboxane A2 production American Journal of Pathology. ,vol. 104, pp. 132- 141 ,(1981)
KS Sakariassen, M Ottenhof-Rovers, JJ Sixma, Factor VIII-von Willebrand factor requires calcium for facilitation of platelet adherence Blood. ,vol. 63, pp. 996- 1003 ,(1984) , 10.1182/BLOOD.V63.5.996.996
A. D. MICHELSON, M. CATTANEO, J. W. EIKELBOOM, P. GURBEL, K. KOTTKE-MARCHANT, T. J. KUNICKI, F. M. PULCINELLI, C. CERLETTI, A. K. RAO, , Aspirin resistance: position paper of the Working Group on Aspirin Resistance Journal of Thrombosis and Haemostasis. ,vol. 3, pp. 1309- 1311 ,(2005) , 10.1111/J.1538-7836.2005.01351.X
L A Fitzgerald, D R Phillips, Calcium regulation of the platelet membrane glycoprotein IIb-IIIa complex. Journal of Biological Chemistry. ,vol. 260, pp. 11366- 11374 ,(1985) , 10.1016/S0021-9258(17)39188-3
B. Sun, N.N. Tandon, N. Yamamoto, M. Yoshitake, J.-i. Kambayashi, Luminometric assay of platelet activation in 96-well microplate. BioTechniques. ,vol. 31, pp. 1174- 1181 ,(2001) , 10.2144/01315DD02
Dean J. Kereiakes MD, Todd Lorenz MD, John J. Young MD, Gilbert Kukielka MD, Michele N. Mueller PBT(ASCP), Lisa Nanniazzi-Alaimo BSc, David R. Phillips MD, Differential effects of citrate versus PPACK anticoagulation on measured platelet inhibition by abciximab, eptifibatide and tirofiban Journal of Thrombosis and Thrombolysis. ,vol. 12, pp. 123- 127 ,(2001) , 10.1023/A:1012991303381
Jack Hirsh, Martin O’Donnell, John W. Eikelboom, Beyond Unfractionated Heparin and Warfarin Current and Future Advances Circulation. ,vol. 116, pp. 552- 560 ,(2007) , 10.1161/CIRCULATIONAHA.106.685974
P. C. J. ARMSTRONG, N. J. TRUSS, F. Y. ALI, A. A. DHANJI, I. VOJNOVIC, Z. N. M. ZAIN, D. BISHOP-BAILEY, M. J. PAUL-CLARK, A. T. TUCKER, J. A. MITCHELL, T. D. WARNER, Aspirin and the in vitro linear relationship between thromboxane A2-mediated platelet aggregation and platelet production of thromboxane A2 Journal of Thrombosis and Haemostasis. ,vol. 6, pp. 1933- 1943 ,(2008) , 10.1111/J.1538-7836.2008.03133.X
V. van Wyk, A. du P. Heyns, Low molecular weight heparin as an anticoagulant for in vitro platelet funtion studies Thrombosis Research. ,vol. 57, pp. 601- 609 ,(1990) , 10.1016/0049-3848(90)90077-P